Nanoviricides (NNVC) Assets (2011 - 2026)
Nanoviricides' Assets was $9.87 million in fiscal Q4 2026 (quarter ended Jun 30, 2026), up 11.9% from $8.82 million a year earlier but down 3.4% from the prior quarter.
Powered by 
Analysis
Nanoviricides (NNVC) Assets (2011 - 2026) Analysis & Trends
From fiscal Q4 2011 onward, Nanoviricides has reported Assets for 61 quarters.
- Assets shows a five-year compound annual growth rate of -20.1% (FY2021 to FY2026).
- In earlier fiscal years, Assets was $8.82 million in FY2025 (-31.2%), $12.82 million in FY2024 (-24.1%), $16.9 million in FY2023 (-28.1%) and $23.49 million in FY2022 (-22.4%).
- Quarterly Assets has moved between $8.36 million (fiscal Q1 2026) and $29.18 million (fiscal Q1 2022) over five years.
- Compared with a year earlier, Assets has increased for three straight quarters, with an average decline of 11.3% over the last eight quarters.
- The best year-over-year quarter for Assets over five years was fiscal Q4 2026 (growth of 11.9%); the worst was fiscal Q3 2024 (a decline of 38.3%).
- Per Business Quant data, NNVC's Assets in the three fiscal quarters before Q4 2026 was $10.22 million (Q3 2026), $12.27 million (Q2 2026) and $8.36 million (Q1 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn | 142.28 Bn |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn | 201.06 Bn |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn | 135.12 Bn |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn | 129.80 Bn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn | 122.03 Bn |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn | 115.83 Bn |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn | 95.64 Bn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn | 49.36 Bn |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn | 201.13 Bn |
| 10 | Nanoviricides | 30.08 Mn | 17.74 Mn | - | 9.87 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 9.87 Mn |
| Mar 31, 2026 | 10.22 Mn |
| Dec 31, 2025 | 12.27 Mn |
| Sep 30, 2025 | 8.36 Mn |
| Jun 30, 2025 | 8.82 Mn |
| Mar 31, 2025 | 10.03 Mn |
| Dec 31, 2024 | 11.57 Mn |
| Sep 30, 2024 | 11.74 Mn |
| Jun 30, 2024 | 12.82 Mn |
| Mar 31, 2024 | 11.46 Mn |
| Dec 31, 2023 | 13.40 Mn |
| Sep 30, 2023 | 15.42 Mn |
| Jun 30, 2023 | 16.90 Mn |
| Mar 31, 2023 | 18.58 Mn |
| Dec 31, 2022 | 20.33 Mn |
| Sep 30, 2022 | 22.08 Mn |
| Jun 30, 2022 | 23.49 Mn |
| Mar 31, 2022 | 25.14 Mn |
| Dec 31, 2021 | 26.81 Mn |
| Sep 30, 2021 | 29.18 Mn |
API Access
Nanoviricides Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=NNVC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "NNVC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=NNVC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();